YEEHAW CANDIDATES Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sergio H who wrote (22942)	2/20/2007 6:51:09 PM
From: Galirayo	of 23958

[VION] If I go purely based on chart formation ... it's VION. Message 23302343 stockcharts.com stockcharts.com FA .. it leaves a lot to be desired. finance.yahoo.com Convertible Cash Infusion .. Delima .. or .. Death Spiral ?? • Vion Completes $60M Notes Offering AP (Tue 1:17pm) • Vion Pharmaceuticals Completes Private Placement of Convertible Notes and Warrants PR Newswire (Tue 12:45pm) At least it has a Heartbeat ... Guess I'll look / see what they are Funding. Hmmm ... this market has a lot of competition. Right ?? Vion Pharmaceuticals Proceeding to Second Stage of Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML Thursday January 25, 8:00 am ET NEW HAVEN, Conn., Jan. 25 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION - News) today announced that it will proceed to the second stage of accrual to its pivotal Phase II trial of Cloretazine® (VNP40101M) in previously untreated elderly patients with de novo poor-risk acute myelogenous leukemia (AML).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next